Signal Detection and Assessment of Herb–Drug Interactions: Saudi Food and Drug Authority SFDA Experience
Drugs - Real World Outcomes - Trang 1-9 - 2023
Tóm tắt
Numerous investigations on herbal medicine that have been undertaken in the past several years demonstrate the general acceptance of its safety. The Saudi Food and Drug Authority (SFDA) established the Herb–Drug Interaction (HDI) project to detect and assess potential HDIs to ensure safety. The aim is to detect safety signals and assess them based on available evidence. First, SFDA-registered herbal products (n = 30) were selected and prioritized based on commonly used herbs. Second, reported potential HDIs were retrieved from the World Health Organization global database of individual case safety reports (VigiBase), AdisInsight®, and the Natural Medicines database. We excluded drugs non-registered by SFDA and labeled interactions in the product information of SFDA, the US Food and Drug Administration (FDA), and the European Medicines Agency (EMA). Finally, a comprehensive evaluation of potential HDIs was carried out using several evidence sources: literature, global cases, local cases, and other relevant documents. The Drug Interaction Probability Scale (DIPS) scale was used to assess the probability of a causal relationship between the interacting herb and drug and the event. The search yielded 566 potential signals, and 41 had published evidence and were referred for assessment. The assessment results using DIPS were: 22 possible (53.6 %), 7 probable (17%), and 12 doubtful (29.2%) interactions. The recommendation was to include probable HDIs in the product information, including turmeric–tacrolimus, etoposide–Echinacea, Ginkgo biloba–ibuprofen, green tea–warfarin, and licorice–thiazides interactions. The HDI project assessed the screening and identification of potential HDIs. The action plan of this project can be used in post-marketing activities to identify potential drug interactions.
Tài liệu tham khảo
Wachtel-Galor S, Benzie IFF. Herbal medicine. In: Herbal medicine: biomolecular and clinical aspects. 2nd ed. CRC Press/Taylor & Francis; 2011. p. 1–10.
Alkhamaiseh SI, Aljofan M. Prevalence of use and reported side effects of herbal medicine among adults in Saudi Arabia. Complement Ther Med. 2020;48:102255.
Al-Faris EA, Al-Rowais N, Mohamed AG, Al-Rukban MO, Al-Kurdi A, Balla Al-Noor MA, et al. Prevalence and pattern of alternative medicine use: the results of a household survey. Ann Saudi Med. 2008;28:4.
Suleiman AK. Attitudes and beliefs of consumers of herbal medicines in Riyadh, Saudi Arabia. J Community Med Health Educ. 2014;4:1–7.
Fugh-Berman A, Ernst E. Herb–drug interactions: review and assessment of report reliability. Brit J Clin Pharmacol. 2001;52:587.
An overview on safety issues of interactions between traditional herbal medicines and pharmaceutical medicines| Western Sydney University ResearchDirect [Internet]. https://researchdirect.westernsydney.edu.au/islandora/object/uws:29501. Cited 7 Nov 2022.
Parveen A, Parveen B, Ahmad S, Parveen R. Challenges and guidelines for clinical trial of herbal drugs. J Pharm Bioallied Sci. 2015;7(4):329–33.
Vizirianakis IS, Spanakis M, Termentzi A, Niopas I, Kokkalou E. Clinical and pharmacogenomic assessment of herb-drug interactions to improve drug delivery and pharmacovigilance. In: Plants in traditional and modern medicine: chemistry and activity. 2010. p. 978–81.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
Pan HY, Wu LW, Wang PC, Chiu PH, Wang MT. Real-world evidence of the herb-drug interactions. J Food Drug Anal. 2022;30(3):316–30.
Skalli S, Bencheikh RS. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Safety 2012;35(10):785–91.
Investigation of drug interactions | European Medicines Agency [Internet]. [cited 2022 Nov 7]. Available from: https://www.ema.europa.eu/en/investigation-drug-interactions.
WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. 2004. https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf.
FDA warns consumers about health risks of herbal coffee products from Malaysia containing undeclared active pharmaceutical ingredients and milk | FDA [Internet]. [cited 2022 Dec 25]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-about-health-risks-herbal-coffee-products-malaysia-containing-undeclared-active.
FDA advises patients not to use Herbal Doctor Remedies medicines | FDA [Internet]. [cited 2022 Dec 25]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-not-use-herbal-doctor-remedies-medicines.
FDA Alert on “Healthy Beauty” Angel Formula Intended for Infants and Children by Moor Herbs | FDA [Internet]. [cited 2022 Dec 25]. Available from: https://www.fda.gov/food/alerts-advisories-safety-information/fda-alert-healthy-beauty-angel-formula-intended-infants-and-children-moor-herbs.
MedWatch: The FDA Safety Information and Adverse Event Reporting Program | FDA [Internet]. [cited 2022 Nov 7]. Available from: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.
Alghamdi W, Al-Fadel N, Alghamdi E, Alghamdi M, Alharbi F, Signal Detection and Assessment of Herb-Drug Interactions: SFDA Experience. 2023. [Online]. Available: https://www.authorea.com/users/602701/articles/633422-signal-detection-and-assessment-of-herbal-drug-interactions-sfda-experience. [Accessed 2023].
VigiBase | UMC [Internet]. WHO Programme for International Drug Monitoring. [cited 2022 Nov 7]. Available from: https://who-umc.org/vigibase/.
AdisInsight by scientists | Springer — International Publisher [Internet]. [cited 2022 Nov 7]. Available from: https://www.springer.com/gp/adis/products-services/adisinsight-databases?gclid=CjwKCAjwtp2bBhAGEiwAOZZTuEzAlLVGXCDRghpgzRxvQZyNxfiDtc0bbVmETBjDedFBbez4Vw7COxoCK-UQAvD_BwE
Natural Medicines Research Collaboration [Internet]. [cited 2022 Nov 7]. Available from: https://naturalmedicines.therapeuticresearch.com/.
Home - PMC - NCBI [Internet]. [cited 2022 Nov 7]. Available from: https://www.ncbi.nlm.nih.gov/pmc/.
Cochrane | Trusted evidence. Informed decisions. Better health. [Internet]. [cited 2022 Nov 7]. Available from: https://www.cochrane.org.
Van Hunsel, van der Kooi D, van de Koppel S, Kroes BH, Woerdenbag HJ. Analysis of reports on adversevdrug reactions related to herbal medicinal products and herbal supplements in the Netherlands received by the National Pharmacovigilance Centre Lareb. Drug Saf. 2022;45:651–61.
Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674–80.
Hou XL, Takahashi K, Kinoshita N, Qiu F, Tanaka K, Komatsu K, et al. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxy vitamin D3 treated Caco-2 cells. Int J Pharm. 2007;337:169–77.
Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar S V., Limtrakul P ngarm. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol. 2002;64:573–82.
Nayeri A, Wu S, Adams E, Tanner C, Meshman J, Saini I, et al. Acute Calcineurin Inhibitor Nephrotoxicity Secondary to Turmeric Intake: A Case Report. Transplant Proc. 2017;49:198–200.
Natural Medicines - Monograph Update: Turmeric Might Interact with Immunosuppressant [Internet]. [cited 2022 Nov 10]. Available from: https://naturalmedicines.therapeuticresearch.com/news/news-items/2017/march/monograph-update-turmeric-might-interact-with-immunosuppressant.aspx.
Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012;27:242–7.
Hansen TS, Nilsen OG. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells. Phytother Res. 2009;23(1):86–91.
Drug Interactions: Echinacea. Medicines Complete (2022).
Probable etoposide interaction with echinacea. J. Diet. Suppl. 2012;9(2):90–5. https://doi.org/10.3109/19390211.2012.682643.
Chevallier A. Stockley's herbal medicines interactions (11th ed.). Pharmaceutical Press. 2023.
Necyk C, Ware MA, Arnason JT, Tsuyuki RT, Boon H, Vohra S. Increased bruising with the combination of long-chain omega-3 fatty acids, flaxseed oil, and clopidogrel. CPJ. SAGE Publications. 2013;146:93.
Budhraja V, Paul D. Warfarin and flax seed oil interaction and a mechanism for Polyunsaturated Fatty Acid and Warfarin interactions. 2009.
Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35:209–19.
Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Therap. 2002;27:391–401.
Shiyong Y, Yijia X, Peng Z, Chong L, Wuming H, Linchun L, et al. Ginkgo biloba extract inhibits platelet activation via inhibition of Akt. Integr. Med. Int. 2015;1:234–42.
Holden W, Joseph J, Williamson L. Use of herbal remedies and potential drug interactions in rheumatology outpatients. Ann Rheum Dis. 2005;64:790.
Haller C, Kearney T, Bent S, Ko R, Benowitz N, Olson K. Dietary supplement adverse events: report of a one-year poison center surveillance project. J Med Toxicol. 2008;4:84–92.
Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 1996;46:1775–6.
Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 2003;167:367.
Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997;336:1108.
Bebbington A, Kulkarni R, Roberts P. Ginkgo biloba: Persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005;20:125–6.
Werba JP, Misaka S, Giroli MG, Shimomura K, Amato M, Simonelli N, et al. Update of green tea interactions with cardiovascular drugs and putative mechanisms. J Food Drug Anal. 2018;26:S72–7.
Lexicomp: Interactions [Internet]. [cited 2022 Nov 10]. Available from: https://online.lexi.com/lco/action/interact.
Wang ZM, Bei C, Bo Z. Green consumption and the risk of stroke"A systematic review and meta-analysis of cohort studies. J Nutr. 2023;107:111936.
Taylor JR, Wilt VM. Probable Antagonism of Warfarin by Green Tea. https://doi.org/10.1345/aph.18238. SAGE Publications; 2016;33:426–8.
Phytochemical Constituents and Pharmacological Effects of Liquorice: A Review. [cited 2022 Nov 10]. Available from: https://www.researchgate.net/publication/328407685_Phytochemical_Constituents_and_Pharmacological_Effects_of_Liquorice_A_Review.
Janne H, Olavi U, Markku J. Effects of low-dose liquorice alone or in combination with hydrochlorothiazide on the plasma potassium in healthy volunteers. Blood Press. 2009;18(4):192–5.
Horwitz H, Woeien VA, Petersen LW, Jimenez-Solem E. Hypokalemia and rhabdomyolysis. J Pharmacol Pharmacother. 2015;6:98–9.
Heidemann HT, Kreuzfelder E. Hypokalemic rhabdomyolysis with myoglobinuria due to licorice ingestion and diuretic treatment. Klin Wochenschr; 1983;61:303–5.
Conn JW, Rovner DR, Cohen EL. Licorice-Induced Pseudoaldosteronism: Hypertension, Hypokalemia, Aldosteronopenia, and Suppressed Plasma Renin Activity. JAMA. American Medical Association 1968;205:492–6.
Chataway SJS, Mumford CJ, Ironside JW. Self-induced myopathy. Postgraduate Medical Journal. BMJ Publishing Group 1997;73:593.
Brouwers AJ, van Meulen J. Licorice hypertention also caused by licorice tea. Ned Tijdschr Geneeskd. 2001;145(15):744–7.
World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. [cited 2022 Nov 7]. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf. 2004.
Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140:513–8.